GnRH analogs: Depot versus short formulations

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 115, Issue SUPPL., 2004, Pages

  Dal Prato, L ^a   Borini, A ^a   Cattoli, M ^a   Bonu, M A ^a   Sereni, E ^a   Flamigni, C ^b  

^a Tecnobios Procreazione   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

GnRH agonist; IVF; Ovarian stimulation; Reduced dose; Triptorelin

Indexed keywords

CHORIONIC GONADOTROPIN; GONADORELIN AGONIST; GONADORELIN DERIVATIVE; GONADOTROPIN; TRIPTORELIN; UROFOLLITROPIN;

CONFERENCE PAPER; DOSE RESPONSE; DRUG FORMULATION; DRUG RESPONSE; FEMALE INFERTILITY; FERTILIZATION IN VITRO; HORMONE ACTION; HUMAN; HYPOPHYSIS FUNCTION; INFERTILITY THERAPY; OVULATION INDUCTION; PHARMACODYNAMICS; PRIORITY JOURNAL;

EID: 2942582352     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejogrb.2004.01.014     Document Type: Conference Paper

References (16)

1. Caspi E., Ron-El R., Golan A., et al. Results of in vitro fertilization and embryo transfer by combined long-acting gonadotropin-releasing hormone analog D-Trp-6-luteinizing hormone-releasing hormone and gonadotropins. Fertil Steril. 51:1989;95-99
2. Zorn J.R., Boyer P., Guichard A. Never on a Sunday: programming for IVF-ET and GIFT (letter). Lancet. 1:1987;385-386
3. Ben-Rafael Z., Lipitz S., Bider D., et al. Ovarian hyporesponsiveness in combined gonadotropin-releasing hormone agonist and menotropin therapy is associated with low serum follicle-stimulating hormone levels. Fertil Steril. 55:1991;272-275
4. Smitz J., Devroey P., Camus M., et al. The luteal phase and early pregnancy after combined GnRH-agonist/HMG treatment for superovulation in IVF or GIFT. Hum Reprod. 3:1988;585-590
5. Porcu E., Dal Prato L., Seracchioli R., et al. Comparison between depot and standard release triptoreline in in vitro fertilization: pituitary sensitivity, luteal function, pregnancy outcome, and perinatal results. Fertil Steril. 62:1994;126-132
6. Porcu E., Filicori M., Dal Prato L., et al. Comparison between depot leuprorelin and daily buserelin in IVF. J Assist Reprod Genet. 12:1995;15-19
7. Parinaud J., Beaur A., Bourreau E., et al. Effect of a luteinizing hormone-releasing hormone agonist (Buserelin) on steroidogenesis of cultured human preovulatory granulosa cells. Fertil Steril. 50:1988;597-602
8. Tureck R.W., Mastroianni L. Jr., Blasco L., et al. Inhibition of human granulosa cell progesterone secretion by a gonadotropin-releasing hormone agonist. J Clin Endocrinol Metab. 54:1982;1078-1080
9. Broekmans F.J., Hompes P.G., Lambalk C.B., et al. Short term pituitary desensitization: effects of different doses of the gonadotrophin-releasing hormone agonist triptorelin. Hum Reprod. 11:1996;55-60
10. Janssens R.M., Vermeiden J.P., Lambalk C.B., et al. Gonadotrophin- releasing hormone agonist dose-dependency of pituitary desensitization during controlled ovarian hyperstimulation in IVF. Hum Reprod. 13:1998;2386-2391
11. Janssens R.M., Lambalk C.B., Vermeiden J.P., et al. Dose-finding study of triptorelin acetate for prevention of a premature LH surge in IVF: a prospective, randomized, double-blind, placebo-controlled study. Hum Reprod. 15:2000;2333-2340
12. Sandow J, Donnez J. Clinical Pharmacokinetics of LHRH analogues. Carnforth, Lancashire, UK: Partenon Publishing; 1990.
13. Elgendy M., Afnan M., Holder R., et al. Reducing the dose of gonadotrophin-releasing hormone agonist on starting ovarian stimulation: effect on ovarian response and in-vitro fertilization outcome. Hum Reprod. 13:1998;2382-2385
14. Feldberg D., Farhi J., Ashkenazi J., et al. Minidose gonadotropin- releasing hormone agonist is the treatment of choice in poor responders with high follicle-stimulating hormone levels. Fertil Steril. 62:1994;343-346
15. Olivennes F., Righini C., Fanchin R., et al. A protocol using a low dose of gonadotrophin-releasing hormone agonist might be the best protocol for patients with high follicle-stimulating hormone concentrations on day 3. Hum Reprod. 11:1996;1169-1172
16. Dal Prato L., Borini A., Trevisi M.R., et al. Effect of reduced dose of triptorelin at the start of ovarian stimulation on the outcome of IVF: a randomized study. Hum Reprod. 16:2001;1409-1414